News of Note—Abbott faces class-action suit over St. Jude defibrillators, and more


Here is Wednesday's medtech news of note.

> St. Jude Medical investors are seeking class-action status in a lawsuit over allegations that the devicemaker—now part of Abbott—did not inform regulators about faulty batteries in its implantable defibrillators. MassDevice article

> Bayer has stopped sales of its Essure birth control implant outside the U.S. for commercial reasons and not safety issues, despite growing concern about the safety of the device. MarketWatch article | FierceMedTech article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.

> Stryker’s Spine unit notched an FDA nod for its 3D-printed TritaniumC Anterior Cervical Cage. It will launch the device in the fourth quarter. Release